Changzhou, China

Huimin Liu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jiangsu Trautec Medical Technology Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huimin Liu. Retrieved from https://idiyas.com/inventor/huimin-liu-2p7obuox

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huimin Liu: Innovator in Recombinant Collagen Technology

Introduction

Huimin Liu is a prominent inventor based in Changzhou, China. He is known for his significant contributions to the field of biotechnology, particularly in the development of recombinant collagen. His innovative work has the potential to impact various medical applications.

Latest Patents

Huimin Liu holds a patent for "Recombinant collagen and preparation method and use thereof." This patent describes a recombinant collagen and a preparation method that includes a full-length collagen α1 chain produced through recombinant expression. The invention focuses on a variant of human type I collagen α1 chain and a variant of human type II collagen α1 chain. The method improves the yield of the target product while eliminating degradation products during the recombinant expression process.

Career Highlights

Huimin Liu is associated with Jiangsu Trautec Medical Technology Co., Ltd., where he continues to advance his research and development efforts. His work in recombinant collagen technology showcases his commitment to innovation in the medical field.

Collaborations

Huimin Liu collaborates with talented individuals such as Jiajia Li and Liping Wang, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Huimin Liu's contributions to recombinant collagen technology exemplify the impact of innovative research in biotechnology. His work not only enhances the understanding of collagen production but also paves the way for future advancements in medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…